Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ORGO will decline by -28.08% over the next 2 Weeks and hit $1.82 by Tuesday, March 31, 2026. In that time frame, ORGO's share price is expected to range between $1.56 and $2.10.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 31, 2026 | 1.56 | 1.82 | 2.10 |
| Mar 30, 2026 | 1.63 | 1.88 | 2.16 |
| Mar 27, 2026 | 1.67 | 1.94 | 2.20 |
| Mar 26, 2026 | 1.81 | 2.07 | 2.34 |
| Mar 25, 2026 | 1.90 | 2.16 | 2.43 |
| Mar 24, 2026 | 1.91 | 2.17 | 2.41 |
| Mar 23, 2026 | 1.97 | 2.23 | 2.48 |
| Mar 20, 2026 | 2.04 | 2.29 | 2.55 |
| Mar 19, 2026 | 2.16 | 2.43 | 2.68 |
| Mar 18, 2026 | 2.24 | 2.52 | 2.76 |
ORGO shares fell -5.14% in Wednesday, March 18, 2026's trading session, dropping from a previous close of $2.53 to move at $2.40. The stock demonstrated notable intraday movement (see ORGO's key stats for a full breakdown), fluctuating between $2.39 and $2.51, a +5.02% trading range. While recent weeks have seen some volatility, ORGO has managed to secure a -16.38% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 680.15K shares changing hands, 15.12K fewer than the previous session. This amounted to $1.63M in total market activity.
Will ORGO Continue Its Downward Trend?
According to analyst ratings and projections for ORGO, Organogenesis Holdings Inc. shares are anticipated to decrease by -14.24%, potentially reaching $2.10 per share by March 31, 2026. Short-term technical indicators for ORGO currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 20 negative trading days within the past 30 sessions. Based on the ORGO stock forecast, now is not the best time to buy ORGO stock because its current trading price is +31.90% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ORGO covering social and institutional perspectives.
ORGO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ORGO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 11.73% to 23.95%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 36.87%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 43.47%, maintains a neutral outlook for the long term. Insights into ORGO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Organogenesis Short-Term Forecasts
ORGO Forecast For Next 5 Days
Our algorithm anticipates Organogenesis (ORGO) stock could hit $2.73 by Mar 25, 2026. This represents a +13.80% fall from today's price, following a -12.29% change over the past five days.
ORGO Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Organogenesis Holdings Inc. (ORGO) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.19, which would mean a -8.75% decrease from the current price of $2.40. Projections for this period range from a high of $3.24 to a low of $1.34.
ORGO Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Organogenesis's price over the next three months point to a rise. ORGO stock is expected to peak at $11.28 on Apr 29, 2026 after potentially dipping to $7.65 on Mar 30, 2026. On average, ORGO is likely to trade around $9.66 in the coming 90 days.
Organogenesis Stock Forecast 2025
Based on our predictive models, Organogenesis (ORGO) is expected to trade between $1.61 and $16.73 throughout 2026. This would result in an average price of $10.27, potentially offering investors a +327.92% return from current levels.
Organogenesis Holdings Inc. Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Organogenesis Holdings Inc. (ORGO) is positioned to show a strong performance in March 2026. The price is predicted to move between $7.65 and $10.37, settling at an average of $8.84. This could translate to a +268.33% gain.
April 2026
Based on current market signals, Organogenesis Holdings Inc. is projected to trend april 2026. We forecast a trading range from $7.80 to $11.28, with a likely average price of $9.82. Investors could expect a potential return of +309.17%.
May 2026
Our predictive algorithms indicate Organogenesis Holdings Inc. stock may see a shift in May 2026. The expected range spans $8.49–$11.01, with an average target of $9.59. This represents a positive outlook and a possible gain of +299.58%.
June 2026
Analyzing established trends, Organogenesis Holdings Inc. looks set to move in June 2026. Projections place the stock between $8.71 and $10.71, averaging around $9.96. This suggests a +315.00% gain from current levels.
July 2026
Market indicators suggest Organogenesis Holdings Inc. could experience notable changes during July 2026. Prices could fluctuate within $8.73 to $13.23, with a midpoint forecast of $11.28. The stock might deliver a +370.00% gain.
August 2026
Forecasting for August 2026, models estimate that Organogenesis Holdings Inc. may undergo key fluctuations. If trends hold, the stock might trade between $5.98 and $10.28, averaging $8.16. This signals a positive trajectory with potential returns around +240.00%.
September 2026
According to our latest forecast models, Organogenesis Holdings Inc. (ORGO) is positioned to show a strong performance in September 2026. The price is predicted to move between $6.63 and $12.13, settling at an average of $10.33. This could translate to a +330.42% gain.
October 2026
Based on current market signals, Organogenesis Holdings Inc. is projected to trend october 2026. We forecast a trading range from $5.19 to $12.27, with a likely average price of $10.25. Investors could expect a potential return of +327.08%.
November 2026
Our predictive algorithms indicate Organogenesis Holdings Inc. stock may see a shift in November 2026. The expected range spans $3.81–$16.73, with an average target of $12.31. This represents a positive outlook and a possible gain of +412.92%.
December 2026
Analyzing established trends, Organogenesis Holdings Inc. looks set to move in December 2026. Projections place the stock between $1.61 and $14.08, averaging around $11.23. This suggests a +367.92% gain from current levels.
January 2027
Market indicators suggest Organogenesis Holdings Inc. could experience notable changes during January 2027. Prices could fluctuate within $0.16 to $11.03, with a midpoint forecast of $7.29. The stock might deliver a +203.75% gain.
February 2027
Forecasting for February 2027, models estimate that Organogenesis Holdings Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $10.28, averaging $7.70. This signals a positive trajectory with potential returns around +220.83%.
March 2027
According to our latest forecast models, Organogenesis Holdings Inc. (ORGO) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $9.69, settling at an average of $6.84. This could translate to a +185.00% gain.
ORGO's history of dividends and stock splits also plays a role in long-term investor confidence.

